- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
Patent holdings for IPC class C07K 16/20
Total number of patents in this class: 292
10-year publication summary
|
20
|
18
|
35
|
17
|
17
|
18
|
17
|
17
|
18
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2861 |
18 |
| Oxford University Innovation Limited | 1544 |
10 |
| Rhode Island Hospital | 200 |
10 |
| Atreca, Inc. | 54 |
8 |
| Regeneron Pharmaceuticals, Inc. | 4303 |
7 |
| Abbott Laboratories | 2397 |
6 |
| Institut Pasteur | 785 |
6 |
| Leidos, Inc. | 211 |
5 |
| Molecular Templates, Inc. | 70 |
5 |
| Seattle Children's Hospital, d/b/a Seattle Children's Research Institute | 127 |
5 |
| Edwards Lifesciences Corporation | 4733 |
4 |
| Humabs Biomed SA | 122 |
4 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2867 |
4 |
| Institute for Research in Biomedicine | 100 |
4 |
| National University Corporation Ehime University | 124 |
4 |
| Rutgers, The State University of New Jersey | 1894 |
4 |
| Sanaria Inc. | 36 |
4 |
| Seattle Children's Hospital | 78 |
4 |
| VIR Biotechnology, Inc. | 144 |
4 |
| The Walter and Eliza Hall Institute of Medical Research | 165 |
4 |
| Other owners | 172 |